At the domestic level, the Shreya Group markets through 3 separate SBU's
Sales & Marketing Setup
Shreya's marketing operations are handled through a field force of over 1000 Sales & Marketing Associates who cover more than 200,000 doctors of major speciality segments viz.,
Efforts of the field personnel are backed by a full-fledged support system comprising of:
Sales Management team at Corporate and Regional level
Marketing Management Team at Corporate
Training Department both at the Corporate & in the field
Medical & Regulatory Cell
Shreya has strategic alliance with Bio Technology General Corporation, USA,
through SciGen, Singapore and Scitech USA to import and market Recombinant Human
Insulin, Hepatitis B Vaccine & Growth Hormone (BTGC acquired by Ferring).
License agreement with Bioton, Poland, to import Recombinant Human Insulin Crystals and finished formulation of Recombinant Human Insulin Cartridges through SciGen.
License agreement with Biotech GmBH, Germany (BBT) to market Gonadotropins in India.
License agreement with Generex Biotechnology Corporation, Canada / USA to distribute and market Oral Recosulin, 'Oral-Lyn' on an exclusive basis in Indian sub-continent which includes India, Nepal, Pakistan, Bhutan, Bangladesh, Srilanka & Myanmar .
Licence agreement with Lallemand and Institute Rosell, France, to market Probiotics.